Pharmaceutical Executive
Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast

Overview
Episodes

Details

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

Recent Episodes

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment
DEC 3, 2025
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment
In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins agency-wide deployment of new agentic AI tools, and a new report suggests Richard Pazdur is stepping down as director of CDER.
play-circle icon
1 MIN
Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound
DEC 2, 2025
Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound
In today’s Pharmaceutical Executive Daily, Eli Lilly reduces the price of Zepbound single-dose vials for self-pay patients, a new report claims the FDA is planning changes to its vaccine approval process following assertions of COVID vaccine–related deaths, and Korea and Australia reorient their pharma launch strategies toward broader regional market opportunities.
play-circle icon
1 MIN
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
DEC 1, 2025
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
In today’s Pharmaceutical Executive Daily, Novo Nordisk files for FDA approval of a higher-dose Wegovy injectable using a priority review voucher, the US and UK agree to eliminate tariffs on pharmaceutical products, and CMS publishes major price cuts for 15 high-cost Medicare drugs under the latest IRA negotiation round.
play-circle icon
1 MIN
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
NOV 26, 2025
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therapy for adolescents and adults with spinal muscular atrophy, and industry experts weigh in on how next-generation CDMOs are evolving to meet rapid market change.
play-circle icon
1 MIN
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
NOV 25, 2025
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes out a $1.5 billion loan to support its long-term growth plan, and Medicare moves closer to releasing negotiated prices for 15 widely used, high-cost medicines.
play-circle icon
2 MIN